Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Gangliosides as modulators of cell function
Zeller, C. B., & Marchase, R. B. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.6.c1341 · Cited by 208
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Self-citationTraveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Wraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
Refractory Skin Injury in Complex Knock-out Mice Expressing Only the GM3 Ganglioside
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Furukawa, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201631200 · Cited by 107
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 84
Cited by
Items 201–300 of 389
Ganglioside GD3 regulates neural stem cell quiescence and controls postnatal neurogenesis
Fuchigami, T., Itokazu, Y., & Yu, R. K. (2023) · Glia · doi:10.1002/glia.24468 · Cited by 21
Phenotype of ST3GAL3 deficient patients: A case and review of the literature
Khamirani, H. J., Zoghi, S., Faghihi, F., Dastgheib, S. A., Hassanipour, H., Tabei, K., Mohammadi, S., Masoudi, M., Poorang, S., Ehsani, E., et al. (2021) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2021.104250 · Cited by 24
Sârbu, M., Ică, R., & Zamfir, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020693 · Cited by 22
Differential regulation of sphingomyelin synthesis and catabolism in oligodendrocytes and neurons
Kilkus, J. P., Goswami, R., Dawson, S., Testai, F. D., Berdyshev, E. V., Han, X., & Dawson, G. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05490.x · Cited by 21
Glycolipid and Glycoprotein Expression During Neural Development
Yu, R. K., & Itokazu, Y. (2014) · Advances in neurobiology · doi:10.1007/978-1-4939-1154-7_9 · Cited by 22
Asthana, P., Vong, J. S. L., Kumar, G., Chang, R. C., Zhang, G., Sheikh, K. A., & Ma, C. H. E. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9430-9 · Cited by 21
Neuromuscular synaptic transmission in aged ganglioside-deficient mice
Zitman, F. M. P., Todorov, B., Verschuuren, J. J. G. M., Jacobs, B. C., Furukawa, K., Furukawa, K., Willison, H. J., & Plomp, J. J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.007 · Cited by 20
Putting a cap on the glycome: Dissecting human sialyltransferase functions
Mohamed, K. A., Kruf, S., & Büll, C. (2024) · Carbohydrate Research · doi:10.1016/j.carres.2024.109242 · Cited by 22
Approaches to homozygosity mapping and exome sequencing for the identification of novel types of CDG
Matthijs, G., Rymen, D., Millón, M. B. B., Souche, E. L., & Race, V. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9445-7 · Cited by 21
Gangliosides play important roles in the nervous system by regulating ion concentrations
Xu, Y., Sun, J., Yang, L., Zhao, S., Liu, X., Su, Y., Zhang, J., & Zhao, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03576-2 · Cited by 19
Gangliosides in Neurodegenerative Diseases
Ledeen, R. W., & Chowdhury, S. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_13 · Cited by 20
Somogyi, A., Petcherski, A., Beckert, B., Huebecker, M., Priestman, D. A., Banning, A., Cotman, S. L., Platt, F. M., Ruonala, M. O., & Tikkanen, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020625 · Cited by 17
Self-citationDaniotti, J. L., Crespo, P. M., & Yamashita, T. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21034 · Cited by 18
Sârbu, M., Fabris, D., Vukelić, Ž., Clemmer, D. E., & Zamfir, A. D. (2022) · Molecules · doi:10.3390/molecules27030743 · Cited by 15
Role of gangliosides in brain aging and neurodegeneration
Mlinac, K., & Bognar, S. K. (2010) · Translational Neuroscience · doi:10.2478/v10134-010-0043-6 · Cited by 20
Role of Complex Gangliosides in Cancer Progression
Bobowski, M., Cazet, A., Steenackers, A., & Delannoy, P. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732765-00001 · Cited by 22
Inokuchi, J., Go, S., Yoshikawa, M., & Strauss, K. A. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.05.025 · Cited by 16
Urinary volatilome analysis in a mouse model of anxiety and depression
Fujita, A., Okuno, T., Oda, M., & Kato, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229269 · Cited by 18
McGonigal, R., & Willison, H. J. (2021) · Journal of Anatomy · doi:10.1111/joa.13562 · Cited by 15
Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
Inamori, K., & Inokuchi, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105368 · Cited by 18
Primer on genes encoding enzymes in sialic acid metabolism in mammals
Wickramasinghe, S., & Medrano, J. F. F. (2011) · Biochimie · doi:10.1016/j.biochi.2011.06.002 · Cited by 19
Conserved Oligomeric Golgi and Neuronal Vesicular Trafficking
Climer, L. K., Hendrix, R. D., & Lupashin, V. V. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_65 · Cited by 19
Eklund, E. A., & Freeze, H. H. (2005) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2005.11.001 · Cited by 22
Gangliosides in human milk and infant formula: A review on analytical techniques and contents
Perea-Sanz, L., García‐Llatas, G., & Lagarda, M. J. (2017) · Food Reviews International · doi:10.1080/87559129.2017.1347671 · Cited by 15
Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency
Aoki, K., Heaps, A. D., Strauss, K. A., & Tiemeyer, M. (2019) · Clinical mass spectrometry · doi:10.1016/j.clinms.2019.03.001 · Cited by 17
OKUDA, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43952-7 · Cited by 17
Hatton, S. L., & Pandey, M. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031089 · Cited by 17
Alecu, J. E., Ohmi, Y., Bhuiyan, R. H., Inamori, K., Nitta, T., Saffari, A., Jumo, H., ZIEGLER, M. L., de Gusmão, C. M., Sharma, N., et al. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62880 · Cited by 14
Roles of Gangliosides in Hypothalamic Control of Energy Balance: New Insights
Inamori, K., & Inokuchi, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155349 · Cited by 15
Itokazu, Y., & Yu, R. K. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_10 · Cited by 14
Platt, F. M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220711 · Cited by 15
Self-citationVruchte, D. T., Jeans, A., Platt, F. M., & Sillence, D. J. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9109-3 · Cited by 18
Self-citationFurukawa, K., Tajima, O., OKUDA, T., Tokuda, N., & Furukawa, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00086-6 · Cited by 19
Yagci, Z. B., Esvap, E., Özkara, H. A., Ülgen, K. Ö., & Özkırımlı, E. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.09.004 · Cited by 16
Spatiotemporal expression of GM1 in murine medial pallial neural progenitor cells
Liour, S. S., Dinkins, M. B., Su, C., & Yu, R. K. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20696 · Cited by 14
Krasnewich, D. M. (2014) · Cancer Biomarkers · doi:10.3233/cbm-130374 · Cited by 13
Ali, A. H., Wei, W., & Wang, X. (2021) · International Journal of Dairy Technology · doi:10.1111/1471-0307.12816 · Cited by 16
Functional Impairment of the Nervous System with Glycolipid Deficiencies
Itokazu, Y., Fuchigami, T., & Yu, R. K. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_14 · Cited by 14
Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level
Zitman, F. M. P., Todorov, B., Furukawa, K., Furukawa, K., Willison, H. J., & Plomp, J. J. (2009) · Synapse · doi:10.1002/syn.20747 · Cited by 13
New Developments in Treating Glycosphingolipid Storage Diseases
Platt, F. M., Jeyakumar, M., Andersson, U., Dwek, R. A., & Butters, T. D. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-25515-x_21 · Cited by 16
Self-citationGangliosides modulate the secretion of extracellular vesicles and their misfolded protein cargo
Monyror, J., Kadam, V., Morales, L. C., Ordóñez, D., Ibanga, J., Zaidi, A. K., McNamara, E., Pink, D., Stenlund, M. J., Reyes, K., et al. (2025) · Science Advances · doi:10.1126/sciadv.ady5212 · Cited by 12
Novel therapeutic approaches for Parkinson’s disease by targeting brain cholesterol homeostasis
Pingale, T. D., & Gupta, G. L. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa063 · Cited by 12
Dookwah, M., Wagner, S. K., Ishihara, M., Yu, S., Ulrichs, H., Kulik, M. J., Zeltner, N., Dalton, S., Strauss, K. A., Aoki, K., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad146 · Cited by 15
Characterization of the Zebrafish Homolog of β-Glucosidase 2: A Target of the Drug Miglustat
Sultana, S., Truong, N. Y., Vieira, D. B., Wigger, J. G. D., Forrester, A. M., Veinotte, C. J., Berman, J. N., & van der Spoel, A. C. (2016) · Zebrafish · doi:10.1089/zeb.2015.1152 · Cited by 13
Svirin, E. P., de Munter, J., Umriukhin, A., Sheveleva, E., Kalueff, A. V., Svistunov, A. A., Morozov, S., Walitza, S., & Strekalova, T. V. (2022) · Biomolecules · doi:10.3390/biom12101434 · Cited by 13
Mijdam, R., Schoenmaker, C., Dyke, E., Moons, S. J., Boltje, T. J., Kasri, N. N., & Lefeber, D. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15934 · Cited by 11
Sandhoff, R., & Sandhoff, K. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_12 · Cited by 13
Manoochehri, J., Dastgheib, S. A., Khamirani, H. J., Mollaie, M., Sharifi, Z., Zoghi, S., Tabei, K., Mohammadi, S., Dehghanian, F., Farbood, Z., et al. (2021) · Human Genome Variation · doi:10.1038/s41439-021-00164-8 · Cited by 11
Saadi, S. M., Calì, E., Khalid, L. B., Yousaf, H., Zafar, G., Khan, H. N., Sher, M., Vona, B., Abdullah, U., Malik, N. A., et al. (2023) · Genes · doi:10.3390/genes14071404 · Cited by 12
Wang, H., Sency, V., McJarrow, P., Bright, A., Huang, Q., Cechner, K., Szekely, J., Brace, J., Wang, A., Liu, D., et al. (2018) · JIMD Reports · doi:10.1007/8904_2018_134 · Cited by 11
Self-citationActivities of genes controlling sphingolipid metabolism in human fibroblasts treated with flavonoids
Moskot, M., Jakóbkiewicz‐Banecka, J., Smolińska, E., Banecki, B., Węgrzyn, G., & Gabig‐Cimińska, M. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9705-x · Cited by 11
Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice
Fortier, M., Cauhapé, M., Buono, S., Becker, J., Menuet, A., Branchu, J., Ricca, I., Mero, S., Dorgham, K., Hachimi, K. H. E., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106564 · Cited by 11
Chowdhury, S., Wu, G., Lu, Z., Kumar, R., & Ledeen, R. W. (2023) · Biomedicines · doi:10.3390/biomedicines11010209 · Cited by 10
Watanabe, S., Lei, M., Nakagawa, E., Takeshita, E., Inamori, K., Shishido, F., Sasaki, M., Mitsuhashi, S., Matsumoto, N., Kimura, Y., et al. (2023) · Brain and Development · doi:10.1016/j.braindev.2023.01.002 · Cited by 11
Abdulkareem, A. A., Shirah, B. H., & Naseer, M. I. (2023) · Genes · doi:10.3390/genes14020354 · Cited by 11
Human genetic defects of sphingolipid synthesis
Dubot, P., Sabourdy, F., & Levade, T. (2024) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12745 · Cited by 10
Unravelling the genetic architecture of autosomal recessive epilepsy in the genomic era
Calhoun, J. D., & Carvill, G. L. (2018) · Journal of Neurogenetics · doi:10.1080/01677063.2018.1513509 · Cited by 10
Force Field Comparison of GM1 in a DOPC Bilayer Validated with AFM and FRET Experiments
Owen, M. C., Karner, A., Šachl, R., Preiner, J., Amaro, M., & Vácha, R. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b05095 · Cited by 11
Adaptive Control Model Reveals Systematic Feedback and Key Molecules in Metabolic Pathway Regulation
Quo, C. F., Moffitt, A. B., Merrill, A. H., & Wang, M. D. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0215 · Cited by 10
ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 5 (ST3GAL5)
Inokuchi, J., & Uemura, S. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_61 · Cited by 10
Schengrund, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126312 · Cited by 10
Inamori, K., Nakamura, K., Shishido, F., Hsu, J.-C., Nagafuku, M., Nitta, T., Ikeda, J., Yoshimura, H., Kodaira, M., Tsuchida, N., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1437668 · Cited by 8
Linking glycosphingolipid metabolism to disease-related changes in the plasma membrane proteome
Monkhouse, H., & Deane, J. E. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240315 · Cited by 9
GD3 synthase deletion alters retinal structure and impairs visual function in mice
Abreu, C. A., Teixeira‐Pinheiro, L. C., Lani‐Louzada, R., da Silva‐Junior, A. J., Vasques, J. F., Gubert, F., Nascimento‐dos‐Santos, G., Mohana‐Borges, R., Matos, E. D. S., Pimentel‐Coelho, P. M., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15443 · Cited by 9
Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer
Àvila, I. V. D. H., Zhang, T., Lorrain, V., de Bruin, F., Spreij, T., Nakayama, H., Iwabuchi, K., García-Vallejo, J. J., Wuhrer, M., van Kooyk, Y., et al. (2024) · Glycobiology · doi:10.1093/glycob/cwae036 · Cited by 10
Gantner, M., Schwarzmann, G. O. H., Sandhoff, K., & Kolter, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.d054734 · Cited by 10
Tang, F., Wang, J., Itokazu, Y., & Yu, R. K. (2020) · ASN NEURO · doi:10.1177/1759091420938175 · Cited by 11
Ică, R., Mlinac, K., Ilić, K., Sajko, T., Munteanu, C. V. A., Zamfir, A. D., & Bognar, S. K. (2022) · Molecules · doi:10.3390/molecules27134056 · Cited by 9
Puljko, B., Stojanović, M., Ilić, K., Bognar, S. K., & Mlinac, K. (2022) · Biomedicines · doi:10.3390/biomedicines10071518 · Cited by 11
Increase of GQ1b in the hippocampus of mice following kindled-seizures
Kato, K., Iwamori, M., & Hirabayashi, Y. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.058 · Cited by 9
Neural Functions of Glycolipids
Schnaar, R. L. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00096-9 · Cited by 9
Dad, R., Malik, U., Javed, A., Minassian, B. A., & Hassan, M. J. (2017) · Gene · doi:10.1016/j.gene.2017.05.041 · Cited by 9
Furukawa, K., Ohmi, Y., Kondo, Y., Bhuiyan, R. H., Tajima, O., Zhang, P., Ohkawa, Y., & Furukawa, K. (2019) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.95.011 · Cited by 9
Furukawa, K., Tsuchida, A., & Furukawa, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00037-4 · Cited by 9
Glycosphingolipids in congenital disorders of glycosylation (CDG)
Pedrayes, A. J., Rymen, D., Ghesquière, B., & Witters, P. (2024) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2024.108434 · Cited by 9
AAV-Mediated Gene Therapy for Glycosphingolipid Biosynthesis Deficiencies
Yang, H., Brown, R. H., Wang, D., Strauss, K. A., & Gao, G. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.02.004 · Cited by 8
The consequences of genetic and pharmacologic reduction in sphingolipid synthesis
Schiffmann, R. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9758-8 · Cited by 9
When ganglioside pathways go awry: congenital disorders and experimental insights
Inamori, K., & Inokuchi, J. (2025) · Journal of Human Genetics · doi:10.1038/s10038-025-01366-6 · Cited by 9
Fundamental Neurochemistry Review: Sphingolipids and Ceramides in Brain Development
Chinnappa, K., Ballorin, F., & Francis, F. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70262 · Cited by 13
Chowdhury, S., Kumar, R., Zepeda, E., DeFrees, S. A., & Ledeen, R. W. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13669 · Cited by 7
The Structural Role of Gangliosides: Insights from X-ray Scattering on Model Membranes
Andreev, K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200103093340 · Cited by 7
Rudy, N. L., Aoki, K., Ananth, A., Holloway, L. W., Skinner, C. D., Hurst, A., Tiemeyer, M., & Steet, R. (2022) · JIMD Reports · doi:10.1002/jmd2.12353 · Cited by 7
Molecular Basis for the Biosynthesis of Oligo- and Polysaccharides
Wilson, I. B. H., Breton, C., Imberty, A., & Tvaroška, I. (2008) · Springer eBooks · doi:10.1007/978-3-540-30429-6_59 · Cited by 10
Loss of ancestral N-glycosylation sites in conserved proteins during human evolution
Kim, D. S., Choi, D., & Hahn, Y. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2362 · Cited by 7
Biosynthetic and genetic pathways related to sialic acid metabolism
Huang, S., van de Ven, E. G. P., Tee, T., & Lefeber, D. J. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111262 · Cited by 6
Sialyltransferase ST 3Gal IV deletion protects against temporal lobe epilepsy
Srimontri, P., Endo, S., Sakamoto, T., Nakayama, Y., Kurosaka, A., Itohara, S., Hirabayashi, Y., & Kato, K. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12838 · Cited by 7
Rescue of GM3 synthase deficiency by spatially controlled, rAAV-mediated ST3GAL5 delivery
Yang, H., Brown, R. H., Wang, D., Strauss, K. A., & Gao, G. (2023) · JCI Insight · doi:10.1172/jci.insight.168688 · Cited by 6
Diseases Associated with Carbohydrates/Glycoconjugates*
Eklund, E. A., Bode, L., & Freeze, H. H. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00098-2 · Cited by 8
Dystonia Due to GM3 Synthase Deficiency
Wang, A. S., & Kilbane, C. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13399 · Cited by 7
Park, H. J., Kim, J. H., Yoon, J. S., Choi, Y. J., Choi, Y. H., Kook, K. H., & Choi, J. H. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.6.1160 · Cited by 7
Congenital Disorders of Glycosylation
Jaeken, J. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_42 · Cited by 6
Anti-inflammatory role of GM1 and modulatory effects of gangliosides on microglia functionsPreprint
Galleguillos, D., Wang, Q., Steinberg, N., Shrivastava, G., Dhami, K., Rubinstein, K., Giuliani, F., Churchward, M. A., Power, C., Todd, K. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.04.975862 · Cited by 6
Sialidases as Potential Therapeutic Targets for Treatment of a Number of Human Diseases
Schengrund, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178733 · Cited by 7
Disordered testosterone transport in mice lacking the ganglioside GM2 / GD2 synthase gene
Furukawa, K., Takamiya, K., Ohmi, Y., Bhuiyan, R. H., Tajima, O., & Furukawa, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13603 · Cited by 5
Inokuchi, J., Go, S., Suzuki, A., Nakagawasai, O., Odaira-Satoh, T., Veillon, L. J., Nitta, T., McJarrow, P., Kanoh, H., Inamori, K., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1387221 · Cited by 5
Mu, D., Yang, Y., Liu, Y., Shen, Y., Liu, H., & Wang, J. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03369-6 · Cited by 5
McGonigal, R., Barrie, J. A., Yao, D., Black, L. E., McLaughlin, M., & Willison, H. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15365 · Cited by 6
Zava, S., Milani, S., Sottocornola, E., Berra, B., & Colombo, I. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.062 · Cited by 5
Yesmin, F., Bhuiyan, R. H., Ohmi, Y., Ohkawa, Y., Tajima, O., Okajima, T., Furukawa, K., & Furukawa, K. (2020) · The Journal of Biochemistry · doi:10.1093/jb/mvaa041 · Cited by 5
Sphingolipidoses and Related Disorders
Laquérriere, A., Bekri, S., Suzuki, K., & Harding, B. (2018) · Wiley eBooks · doi:10.1002/9781119013112.ch29 · Cited by 2
Metadata
- Authors
- Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., & Crosby, A. H.
- Affiliations
- University of London (GB)
- University of Arizona (US)
- University of Oxford (GB)
- Rainbow Babies & Children's Hospital (US)
- Corresponding author
- Crosby, Andrew H
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-10-24
- Volume
- 36
- Issue
- 11
- Pages
- 1225-1229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2161292836
- Cited by
- 389
- References
- 22
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 29 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 27 · 2013: 19 · 2012: 18
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GM3 synthase, loss-of-function mutations, autosomal recessive inheritance, founder effect, Old Order Amish, ganglioside biosynthesis, GM3 ganglioside, lactosylceramide, glycosphingolipids, blindness, sialyltransferase, linkage mapping
- MeSH terms
- Blindness, Developmental Disabilities, Chromosomes, Human, Pair 2, Epilepsy, Female, G(M3) Ganglioside, Genes, Recessive, Glycosphingolipids, Humans, Infant, Infant, Newborn, Male, Pedigree, Sialyltransferases, Syndrome, Codon, Nonsense, Founder Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.